期刊文献+

晚期肺癌患者诊断延迟的原因分析 被引量:3

Analysis of delay in diagnosis of advanced lung cancer
原文传递
导出
摘要 为了探讨肺癌诊断延迟的原因,回顾性分析86例晚期肺癌患者诊断延迟的原因,包括69例非小细胞肺癌和17例小细胞肺癌。结果:患者中位诊断延迟时间为8.2周(1.7~83.0周),其中患者延迟时间为4周(0~78周),医生延迟时间为1.3周(0.3~52.3周)。29.1%(25/86)的患者首诊时被误诊,这类患者的医生延迟时间为13.6周(3.9~52.3周),而首诊时怀疑为肺癌患者的医生延迟时间为1.1周(0.3~5周),明显较短,P<0.001。以肺外表现为首发症状的患者,误诊率高达62.5%(5/8)。初步研究结果提示,晚期肺癌的诊断延迟原因较复杂,既有患者的因素也有医生的因素,有必要对两种情况进行前瞻性研究。 The objective of this study was to explore the delay in diagnosis of patients with advanced lung cancer. The di agnostic delay in 86 patients with advanced lung cancer was analyzed retrospectively, which included 69 patients with non-small cell lung cancer and 17 patients with small cell lung cancer. The overall median diagnostic delay was 8.2 w (1.7-83.0 w), and patient's delay was 4 w (0-78 w), doctor's delay was 1.3 w (0. 3--52. 3 w). A total of 29.1%(25/86) patients who were misdiagnosed had longer doctors delay of 1.3 w (0. 3 52.3 w) ,P%0. 001, and than the patients who were suspected for lung cancer, whose doctors delay were 1. lw(0. 3-5 w). The misdiagnosis rate in patients with extrapulmonary presentations as first symptom was 62. 5%(5/8). In conclusion, the reasons of diagnosis delay in advanced lung cancer was complicated. Patients and doctors should all take responsibility for diagnostic delay in patients with lung cancer. It is necessary to conduct perspective study for these conditions.
出处 《中华肿瘤防治杂志》 CAS 2009年第5期384-385,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 肺肿瘤/诊断 患者延迟 医生延迟 lung neoplasms/diagnosis patient's delay doctor's delay
  • 相关文献

参考文献9

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008[J]. CA Cancer J Clin, 2008, 58(2): 71-96.
  • 2Spiro S G, Gould M K, Colice G L. Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)[J]. Chest, 2007, 132(3 Suppl): 149-160.
  • 3Jensen A R, Mainz J, Overgaard J. Impact of Delay on Diagnosis and Treatment of Primary Lung Cancer[J]. Acta Oncol, 2002, 41(2):147-152.
  • 4Koyi H, Hillerdal G, Branden E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999[J]. Lung Cancer, 2002, 36(1):9-14.
  • 5Comer J, Hopkinson J, Fitzsimmons D, et al. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis[J]. Thorax, 2005, 60(4): 314-319.
  • 6Hamilton W, Peters T J, Round A, et al. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study[J]. Thorax, 2005, 60(12): 1059-1065.
  • 7吕梅君,陈子丹,施海燕,周彩存.肺癌患者就诊及治疗延迟对预后的影响[J].中华肿瘤防治杂志,2006,13(19):1499-1501. 被引量:1
  • 8Bjerager M. Delay in diagnosis of lung cancer in general practice [J]. BrJ Gen Praet, 2006, 56(532): 863-868.
  • 9Koyi H, Hillerdal G, Branden E. Patient's and doctors' delays in the diagnosis of chest tumors[J]. Lung cancer, 2002, 35(1) :53-57.

二级参考文献6

  • 1Salvador P F,Carmen M M,Sonia P D,et al.Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer[J].Journal of Clinical Epidemiology,2003,56 (9):820-825.
  • 2Gonzalez J M,Castro F J,Barrueco M,et al.Delaysin the diagnosis of lung cancer[J].Arch Broncomeumol,2003,39(10):437-441.
  • 3Inoue M,Sawabata N,Takeda S,et al.Results of surgical intervention for p-stage Ⅲ A (N2) non-small cell lung cancer:Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe[J].J Thorac Cardiovasc Surg,2004,127 (4):1100-1106.
  • 4Myrdal G,Lambe M,Hillerdal G,et al.Effect of delays on prognosis in patients with non-small cell lung cancer[J].Thorax,2004,59(1):45-49.
  • 5Moody A,Muers M,Forman D.Delays in managing lung cancer[J].Thorax,2004,59(1):1-3.
  • 6Simunovic M,Gagliardi A,McCready D,et al.A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario[J].Can Med Assoc J,2001,165(4):421-425.

同被引文献34

  • 1李付海,石安辉,朱广迎.局部晚期非小细胞肺癌同步放化疗进展[J].中国肿瘤,2009,18(10):831-834. 被引量:11
  • 2谢晓冬,郑振东.分子靶点药物吉非替尼治疗复发难治性非小细胞肺癌的现状[J].中国实用内科杂志,2005,25(8):688-690. 被引量:9
  • 3许洋.蛋白质指纹图谱技术在实验诊断与临床医学中的研究进展[J].基础医学与临床,2007,27(2):134-142. 被引量:36
  • 4Ocak S, Chaurand P, Massion P P. Mass spectrometry based proteomic profiling of lung cancer[J]. Proc Am Thorac Soc, 2009,6(2):159-170.
  • 5Salomon D S, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptor and tis ligands in primary non small cell lung cancers and adjacent benign lung[J]. Crit Rev Oncol Hematol, 1995,19(3), 183-232.
  • 6Rusch V, Bselga J, Cordon-Cardo C, er al. Differential expression of the epidermal growth factor receptor and tis ligands in primary non-small cell lung cancers and adjacent benigh lung[J]. Cancer Res,1993, 53(10 Suppl) :2379-2385.
  • 7Chang A, Parikh P, Thongprasert S, et al. Gefitinib in patients of Asian origin with refractory adbanced non-small cell lung cancer:subset analysis from the ISEL study[J]. Thorac Oncol, 2006, 1(8) :847-855.
  • 8Kris M G, Natale R B, Herbst R S, et al. A phase Ⅱ trial of um-and docetaxel based regimens(IDAEL2)[J]. Proc Am Soc Clin Oncol, 2002, 21:292a.
  • 9Curer T, Vrdoljak E, Gaafar R, et al. Phase Ⅱ , open label, randomaize study (SIGN) of single agent gefitinib(IRESSA) or docetaxel as second-line therapy in patients with advanced (stage [Ⅲbor Ⅳ ) non small cell lung cancer[J]. Anticancer Drugs, 2006,17(4):401- 109.
  • 10Quoix E, Breton J L, Ducolone A, et al. First line chemothera py with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase I1 study of 3 week versus 4-week schedule[J]. Lung Cancer, 2005, 47(3) :405- 412.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部